New York, 01 November - Pfizer, the world leader in the pharmaceutical industry, tripled its net profit to 3.7 billion dollars in the third quarter compared to a year earlier and raised its 2011 estimates. So did the American group, whose results exceeded market expectations. Earnings per share for the quarter were 62 cents (from the 55-56 average expected by analysts) thanks in particular to the sale of the Capsugel division. Turnover increased by 7.48% to 17.2 billion, against expectations of 16.4 billion. For 2011, Pfizer raised its earnings per share estimates to $1.20-1.30, from $1.09-1.24 previously, and earnings adjusted for non-continuing operations to $2.24-2.29, from $2.16-2.26. Revenue forecasts were instead maintained at 66.2-67.2 billion. red-pal 01-11-11 12:44:20 (0129) 5
Corriere della sera.it
